21:54 , Feb 9, 2017 |  BC Week In Review  |  Company News

Vancocin vancomycin news

In a federal lawsuit, the U.S. Federal Trade Commission alleged that the Shire ViroPharma Inc. subsidiary of Shire abused the Citizen's Petition process and violated antitrust laws to delay generic competition for antibiotic Vancocin vancomycin....
00:51 , Feb 8, 2017 |  BC Extra  |  Company News

FTC suit alleges Shire abused FDA process

In a federal lawsuit , the U.S. Federal Trade Commission alleged that the Shire ViroPharma Inc. subsidiary of Shire plc (LSE:SHP; NASDAQ:SHPG) abused the Citizen's Petition process and violated antitrust laws to delay generic competition...
07:00 , Aug 1, 2016 |  BC Week In Review  |  Company News

ANI Pharmaceuticals sales and marketing update

ANI launched a generic version of Nilandron nilutamide from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) in the U.S. The oral testosterone blocker is marketed to treat metastatic prostate cancer. Under a 2013 deal, Sanofi granted Covis...
02:03 , Aug 7, 2015 |  BC Extra  |  Financial News

Cold Genesys raises $10M in series B

Cold Genesys Inc. (Santa Ana, Calif.) raised $10 million in a series B round co-led by existing investor Ally Bridge Group and new investor WI Harper Group. New investors Whitesun Healthcare Ventures and Song Hong...
07:00 , May 21, 2015 |  BC Innovations  |  Product R&D

Aduro's STING

Aduro Biotech Inc. 's preclinical STING agonists have caught the eye of pharmas for their ability to stimulate immunity in distal tumors, which suggests the compounds might be among the first immunotherapy agents for metastases....
08:00 , Dec 15, 2014 |  BC Week In Review  |  Financial News

ANI Pharmaceuticals financial update

ANI Pharmaceuticals Inc. (NASDAQ:ANIP), Baudette, Minn.   Business: Generics   Date announced: 2014-12-10   Note: ANI raised $18.8 million through the sale of senior convertible notes following the exercise by underwriters of their option to...
08:00 , Dec 8, 2014 |  BC Week In Review  |  Financial News

ANI Pharmaceuticals completes private placement of senior convertible notes

ANI Pharmaceuticals Inc. (NASDAQ:ANIP), Baudette, Minn.   Business: Generics   Date completed: 2014-12-05   Type: Private placement of senior convertible notes   Raised: $125 million   Shares outstanding prior: 11.3 million   Underwriters: Guggenheim Securities;...
07:00 , Sep 1, 2014 |  BC Week In Review  |  Company News

Shire, ANI Pharmaceuticals deal

Shire sold ANI U.S. rights to 125 and 250 mg Vancocin vancomycin capsules for Clostridium difficile-associated diarrhea (CDAD) and approved ANDAs for 500 mg, 1 g and 10 g injectable and 250 and 500 mg...
07:00 , Jul 28, 2014 |  BC Week In Review  |  Clinical News

GVAX Pancreas cancer vaccine regulatory update

Aduro said FDA granted breakthrough therapy designation to the combination of CRS-207 and GVAX Pancreas cancer vaccine to treat pancreatic cancer. The designation was based on data from a Phase II trial of the combination...
07:00 , Jul 28, 2014 |  BC Week In Review  |  Clinical News

CRS-207 regulatory update

Aduro said FDA granted breakthrough therapy designation to the combination of CRS-207 and GVAX Pancreas cancer vaccine to treat pancreatic cancer. The designation was based on data from a Phase II trial of the combination...